Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Uniqure Ord Shs (NQ: QURE )

34.88 USD UNCHANGED
Streaming Delayed Price Updated: 4:45 PM EDT, Apr 13, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 34.88
Bid (Size) 31.00 (2)
Ask (Size) 36.99 (4)
Prev. Close 34.88
Today's Range 34.88 - 34.88
52wk Range 28.58 - 71.45
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
uniQure Announces Publications of Preclinical Data for AMT-130 in Huntington’s Disease Showing Safety of Administration in NHPs and Widespread Long-Term HTT-Lowering in the Brain
Publication in Science Translational Medicine shows local striatal delivery of microRNA-gene therapy results in widespread brain huntingtin protein lowering in Huntington’s disease minipigs 
From GlobeNewswire News Releases
uniQure Announces Completion of Enrollment in First Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
From GlobeNewswire News Releases

Performance

YTD
-5.11%
-5.11%
1 Month
+3.13%
+3.13%
3 Month
-9.05%
-9.05%
6 Month
-4.23%
-4.23%
1 Year
-33.88%
-33.88%

More News

Read More
uniQure to Participate in Multiple Upcoming Industry Conferences in April
From GlobeNewswire News Releases
uniQure Announces Findings from Reported Case of Hepatocellular Carcinoma (HCC) in Hemophilia B Gene Therapy Program
From GlobeNewswire News Releases
Look Under The Hood: RYJ Has 17% Upside
Tags ETFs
From ETF Channel
uniQure Announces 2020 Financial Results and Highlights Recent Company Progress
From GlobeNewswire News Releases
uniQure to Participate in Multiple Upcoming Industry Conferences in March
From GlobeNewswire News Releases
Why Humanigen, uniQure, bluebird bio, Amphastar Are Rallying Monday
Tags Small Cap BLUE Market News
From Benzinga
Uniqure's Hemophilia B Gene Therapy Unlikely To Be Cause Of Liver Cancer Reported In One Patient
Tags Small Cap Market News Health Care
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tags Pre/Market Outlook Market News CMRX
From Benzinga
Uniqure Stock Pops After Gene Therapy Acquitted In Cancer Diagnosis
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.